Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: A study of 204 cases

American Journal of Hematology

Volumn 65, Issue 3, 2000, Pages 215-222

  Okajima, Kenji ^a,b   Sakamoto, Yumi ^a   Uchiba, Mitsuhiro ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Bleeding; Clinical manifestations; Disseminated intravascular coagulation; Heterogeneity; Incidence; Organ failure

Indexed keywords

ANTIPLASMIN; FIBRIN DEGRADATION PRODUCT; PLASMIN; THROMBIN ANTITHROMBIN COMPLEX;

AORTA ANEURYSM; ARTICLE; BLEEDING; CLINICAL FEATURE; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRINOLYSIS; HEMATOLOGIC DISEASE; HUMAN; INCIDENCE; INFECTION; LIVER DISEASE; MAJOR CLINICAL STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SOLID TUMOR;

ANTIPLASMIN; ANTITHROMBIN III; BLOOD COAGULATION; DISSEMINATED INTRAVASCULAR COAGULATION; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HUMAN; INCIDENCE; PEPTIDE HYDROLASES; PLASMIN;

EID: 0033792596     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8652(200011)65:3<215::AID-AJH7>3.0.CO;2-7     Document Type: Article

References (31)

1. Clinical aspects of disseminated intravascular coagulation: A clinician's point of view
2. Severe symmetrical gangrene of the extremities
3. Case of fatal hemorrhagic diathesis with premature detachment of placenta
4. The nature of the blood coagulation mechanism and its relationship to some unsolved problems in obstetrics and gynecology
5. Disseminated intravascular coagulation syndrome
6. Pathophysiologic and biochemical events in disseminated intravascular coagulation: Dysregulation of procoagulant and anticoagulant pathways
7. Alterations in blood coagulation induced by bacterial endotoxin. I. In vivo (generalized Shwartzman reaction)
8. Role of leukocytes in the activation of intravascular coagulation in patients with septicemia
9. Cytokines and endothelial cell biology
10. Consequences of leukocytes-vessel wall interactions in inflammatory and immune reactions
11. The microcirculation and inflammation: Modulation of leukocyte-endothelial cell adhesion
12. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation
13. Chemokine regulation of human megakaryocytopoiesis
14. Disseminated intravascular coagulation: Findings in 346 patients
15. 1-proteinase inhibitor complex in patients with disseminated intravascular coagulation: Pathophysiologic implications
16. Detection of soluble intermediates of the fibrinogen-fibrin monomers
17. Gerinnungsphysiologische schnellmethods zur bestimmung des fibrinogen
18. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay
19. 2-macroglobulin and plasmin complex in plasma
20. 2-plasmin inhibitor deficiency
21. Preoperative disseminated intravascular coagulation associated with aortic aneurysms
22. Chronic consumption coagulopathy accompanying abdominal aortic aneurysms
23. Plasma concentration of tissue factor and factor VII in patients after abdominal surgery
24. The defibrination syndrome: Clinical features and laboratory diagnosis
25. Endothelial cells: Role in infection and inflammation
26. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock
27. Plasma levels of soluble E-selection in patients with disseminated intravascular coagulation
28. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor
29. Pathogenesis of disseminated intravascular coagulation in sepsis
30. Heparin therapy in septicemia with disseminated intravascular coagulation
31. Heparin therapy of diffuse intravascular coagulation